Back

First Report of Evaluation of Variant rs11190870 nearby LBX1 Gene with Adolescent Idiopathic Scoliosis Susceptibility in a South-Asian Indian Population.

Singh, H.; Shipra, S.; Gupta, M.; Bhau, P.; Chalotra, T.; Manotra, R.; Gupta, N.; Gupta, G.; Pandita, A. K.; Butt, M. F.; Sharma, R.; Pandita, S.; Singh, V.; Garg, B.; Rai, E.; Sharma, S.

2022-06-28 genetic and genomic medicine
10.1101/2022.06.28.22276987
Show abstract

LBX1 is a developmental gene involved in skeletal muscle development and somatosensory functioning and proven to be an important gene involved in Adolescent Idiopathic Scoliosis (AIS) etiology. Variant rs11190870 is located 7.5 kb downstream of LBX1 gene and is part of haplotype that is reported to provide risk for AIS. Several studies, including various Genome Wide Association, replication and meta-analyses studies have implicated its association with AIS in different populations. However, any such study is altogether lacking in South-Asian Indian populations. In this first genetic association study for AIS from the region, we tried to replicate association of variant rs11190870 in 95 AIS cases and 282 healthy non-AIS controls from Northwest India. The genotyping was carried out on a Realtime PCR using TaqMan allele discrimination assay and the variant was found to be following Hardy Weinberg equilibrium. The statistical analyses of the genotyping data did not show significant association (p=0.66) of variant rs11190870 with AIS in the population of Northwest India. The results are interesting findings in a population that has never been studied before for AIS susceptibility. However, the findings can be attributed to under power study thus, need evaluation in a large sample set from the population. Interestingly, frequency distribution of the variant in Indian control population datasets was found to be different than other global populations. Linkage Disequilibrium (LD) differences in the genomic region were also observed in these populations while analysing 1000Genomes phase 3 data. It hints at existence of either haplotypic differences in LBX1 locus in South-Asian Indian populations with respect to other populations or genetic heterogeneity in AIS susceptibility. This lays a foundation for genome wide association study (GWAS) in Indian populations cohort, for better understanding of AIS, a task we are pursuing.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
American Journal of Medical Genetics Part A
based on 14 papers
Top 0.1%
11.3%
2
Scientific Reports
based on 701 papers
Top 12%
11.3%
3
PLOS ONE
based on 1737 papers
Top 57%
7.6%
4
Frontiers in Genetics
based on 32 papers
Top 0.2%
6.4%
5
Journal of Medical Genetics
based on 22 papers
Top 0.4%
3.0%
6
Human Molecular Genetics
based on 28 papers
Top 0.7%
3.0%
7
Genes
based on 21 papers
Top 0.4%
2.5%
8
Journal of Clinical Medicine
based on 77 papers
Top 6%
2.5%
9
Orphanet Journal of Rare Diseases
based on 15 papers
Top 0.5%
2.5%
50% of probability mass above
10
European Journal of Human Genetics
based on 25 papers
Top 0.8%
2.5%
11
Human Mutation
based on 14 papers
Top 0.6%
2.5%
12
Cureus
based on 64 papers
Top 8%
2.3%
13
Brain and Behavior
based on 19 papers
Top 2%
1.6%
14
International Journal of Molecular Sciences
based on 39 papers
Top 2%
1.6%
15
BMJ Open
based on 553 papers
Top 45%
1.3%
16
Biology
based on 11 papers
Top 0.6%
1.3%
17
Journal of Clinical Pathology
based on 11 papers
Top 0.8%
1.2%
18
PLOS Genetics
based on 39 papers
Top 4%
1.2%
19
Aging
based on 18 papers
Top 3%
1.2%
20
Frontiers in Oncology
based on 34 papers
Top 5%
1.2%
21
Journal of Neurotrauma
based on 11 papers
Top 2%
0.8%
22
Open Heart
based on 18 papers
Top 5%
0.8%
23
Human Genetics
based on 14 papers
Top 2%
0.8%
24
Genetics in Medicine
based on 57 papers
Top 5%
0.8%
25
Frontiers in Pediatrics
based on 24 papers
Top 3%
0.8%
26
Human Genomics
based on 13 papers
Top 2%
0.8%
27
Movement Disorders
based on 49 papers
Top 4%
0.7%
28
Frontiers in Psychiatry
based on 56 papers
Top 8%
0.7%
29
Cancers
based on 57 papers
Top 7%
0.7%
30
npj Genomic Medicine
based on 18 papers
Top 3%
0.7%